Analysis of topic evolution over the study period reveals three significant trends in public perception
The KD, which was originally used for controlling epilepsy, especially hard-to-control epilepsy (12), is now being used in the management of obesity (13), polycystic ovary syndrome (14), cancer (15), diabetes mellitus (16), and traumatic brain injury (17), as well as amyotrophic lateral sclerosis (18), mitochondrial myopathies (19), primary sarcopenia (20), and other pathologic conditions (21)
[1] [2] Tirzepatide is also available under the brand name Zepbound for weight management in adults with obesity or overweight with weight-related comorbidities
Travel introduces a whole new set of risks, from hot cars to airport security to tropical destinations
They are fragile, expensive to manufacture (fermentation), and require strict fasting rules to survive digestion